Delivery Order SPE2DB20D3103-SPE2DB23FM4Q1
Award Date 2/14/23
Potential Completion Date 2/15/23
Potential Value $2.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This contract award is for the delivery of Doxorubicin Liposome 50mg/25ml vials to the U.S. Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,500.00 contract has a firm fixed price and an ultimate completion date of February 12, 2024. This is a delivery order contract without any set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,700.00 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4564312466 - Doxorubicin Liposome 20mg/10ml 10ml, with a period of performance through April 18, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the...
- This is a $3,404.64 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 50mg/25ml vials of the drug doxorubicin liposome, a chemotherapy medication. The award has a completion date of July 7, 2025 and is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Doxorubicin Liposome 20mg/10ml in 10ml vials, with a contract ceiling value of $1,922.10 and an ultimate completion date of November 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- This federal contract award, valued at $111,908.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
- This delivery order, valued at $1,069.20, was awarded to AmerisourceBergen Drug Corp on October 4, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of October 6, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child order under a larger indefinite delivery contract vehicle, this delivery order represents one of numerous...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,101.32 by the Defense Logistics Agency (DLA) on October 20, 2025, with an ultimate completion date of November 10, 2025. The delivery order, designated as a firm fixed-price contract with no set-aside, covers IMLYGIC 100 Million PFU/ML VLML, a specialized pharmaceutical product to support federal medical supply needs. The award represents a...
- This federal contract award is a delivery order with a firm fixed price of $21,501.64 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is not set aside and has an ultimate completion date of June 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA, which provides a comprehensive global pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) with a delivery order valued at $1,443.79. The contract has a period of performance through March 12, 2024 and is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award is a delivery order with a firm fixed price of $2,664.30, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of June 5, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...